Comprehensive Review on the Formulation and Evaluation of Antiseptic Creams

Topical creams represent a fundamental class of semisolid dosage forms within pharmaceutical science, defined pharmacopeially as viscous, liquid, or semisolid biphasic emulsions engineered specifically for external application to either the skin or accessible mucous membranes. Structurally, these systems are characterized by a heterogeneous distribution of two mutually immiscible liquid phases: a lipophilic (oil) phase and a hydrophilic (aqueous) phase. [4] One phase is physically fragmented into microscopic droplets—referred to as the internal or dispersed phase—and distributed uniformly throughout the continuous or external phase. This structural architecture is thermodynamically unstable due to the high interfacial tension between the oil and water molecules. To prevent natural degradation processes such as coalescence, flocculation, and phase separation, the system requires the addition of amphiphilic emulsifying agents. These agents line the interfacial boundaries, lowering surface tension and forming a mechanical or electrostatic barrier that keeps the droplets suspended.[8]

From a functional perspective, creams serve as vital vehicles within modern topical drug delivery frameworks. Their primary purpose is to evenly distribute active pharmaceutical ingredients (APIs) across human skin, ensuring that therapeutic agents are spread consistently over the target surface. The physical structure of a cream is carefully optimized to control how the encapsulated drug is released. When applied, the continuous phase of the cream interacts with the skin’s surface, while the dispersed droplets act as micro-reservoirs that gradually release the API. By altering the balance of the oil and water phases, formulation scientists can tailor the cream's properties. For instance, oil-in-water (O/W) systems offer a non-greasy feel and wash off easily with water, making them ideal for acute conditions. Conversely, water-in-oil (W/O) systems provide an emollient, protective barrier that slows down drug release, which is highly beneficial for treating chronic, dry skin conditions.[10]

The Biological Barrier of Human Skin and Microbial Threats

The human skin is the body's largest organ, serving as a complex, multi-layered biological barrier that shields internal physiological systems from a wide range of environmental threats. This vital barrier protects against mechanical trauma, ultraviolet radiation, and pathogenic invasion. Structurally, this protective function is driven by the outermost layer of the epidermis, known as the stratum corneum. Often described using a "brick-and-mortar" model, the stratum corneum consists of flattened, protein-rich dead cells (corneocytes, the "bricks") tightly embedded within a highly organized extracellular matrix of lipids (ceramides, cholesterol, and free fatty acids, the "mortar"). This unique architecture creates a highly effective waterproof seal that prevents transepidermal water loss and blocks harmful external pathogens from entering the body. [11]

Fig: The Biological Barrier of Human Skin and Microbial Threats

Formulation Of Antiseptic Creams

Evaluation Tests for Antiseptic Creams

To ensure therapeutic efficacy, physical uniformity, consumer acceptability, and long-term stability, formulated antiseptic creams must undergo rigorous, multi-parametric quality control testing.

6.1 Physical and Physicochemical Evaluation

A. Appearance and Organoleptic Properties

The cream is visually inspected under standardized lighting conditions against a white background to evaluate basic sensory parameters:

• Color: Must show uniform color distribution without discoloration, modeling, or yellowing over time.
• Odor: Evaluated for consumer acceptability. Must remain free from off-odors caused by the oxidative rancidity of unsaturated lipid excipients.
• Texture: Assessed by rubbing a small sample between the thumb and forefinger to check for smooth application and ensure there is no graininess or grittiness.
• Homogeneity: Evaluated qualitatively by spreading a thin film of cream onto a transparent glass slide. It must show a uniform surface structure without visible phase separation, oil streaking, or particulate clumping.

B. pH Determination

Because human skin maintains a slightly acidic surface pH (4.5 text to  6.0) to support its protective acid mantle, topical formulations must be carefully balanced. The pH is measured using a calibrated digital pH meter. A 10% w/v aqueous dispersion of the cream is prepared by dispersing 10 g of the formulation in 90 mL of distilled water under mild agitation. The glass electrode is immersed into the dispersion, and the reading is allowed to stabilize. The ideal target pH range for an antiseptic cream is 5.0 text to  7.0 to ensure compatibility with the skin barrier and minimize the risk of tissue irritation or chemical dermatitis [7, 12].

C. Viscosity and Rheological Profile

Viscosity is quantified using a rotational viscometer (e.g., Brookfield viscometer) with a suitable spindle (such as T-bar spindles) at varying rotational speeds at 25°C. Viscosity data are critical because they directly impact several product characteristics:

• Stability: High viscosity at rest prevents oil droplets from moving, which helps suppress creaming or phase separation.
• Spreadability: The cream must show non-Newtonian, pseudoplastic (shear-thinning) flow behavior. This means its viscosity drops under mechanical shear, allowing it to spread easily when applied to the skin.
• Application Ease: Thixotropic properties allow the formulation to break down structurally during extrusion or spreading, and then recover its original viscosity once the shear stress is removed. This prevents the product from running off the target area.

D. Spreadability

Spreadability measures the ease with which a cream applies to skin or affected tissues. It is quantified using a parallel-plate apparatus. A designated volume of cream is placed between two ground glass slides. A specified weight  is applied to the upper slide, compressing the cream into a uniform circle. The upper slide is then pulled along a fixed distance by a suspended weight. The time taken for the slides to separate completely is recorded.

 [3]. A higher spreadability value indicates that the product spreads easily with minimal mechanical pressure, which is ideal when treating painful or tender wound sites.

E. Extrudability Test

This test measures the ease with which the cream is expelled from its final packaging. Standard collapsible aluminum or plastic tubes are filled with the formulation and sealed. A constant weight or uniform mechanical force is applied to the crimped base of the tube. The weight of the cream extruded through the nozzle over a set period is quantified. Optimal extrudability ensures that the consumer can smoothly remove the product from the packaging without requiring excessive force..

F. Washability

Washability evaluates how easily the product can be removed from the skin after use, which directly affects patient compliance. A small amount of cream is applied to a designated area of the forearm. It is then washed under a gentle stream of tap water at 25text °C without vigorous scrubbing. O/W formulations should wash away cleanly without leaving a greasy, water-resistant residue.

7. Microbiological Evaluation Protocols

Topical antiseptic creams must demonstrate clear antimicrobial efficacy against standard target pathogens. Agar well diffusion method is The assay provides a qualitative and semi-quantitative measure of antimicrobial activity against a standard panel of pathogens:

• Gram-Positive Bacteria: Staphylococcus aureus
• Gram-Negative Bacteria: Escherichia coli, Pseudomonas aeruginosa
• Fungi/Yeast: Candida albicans

7.3 Determination of Minimum Inhibitory Concentration (MIC)

The MIC represents the lowest concentration of the active formulation that completely prevents visible microbial growth. To determine the MIC of a semisolid cream, a standard weight of the product is extracted into an appropriate solvent system (such as PBS containing 0.1% Tween 80). This stock extract undergoes serial two-fold dilutions in sterile nutrient broths within a 96-well microtiter plate.

Each well is inoculated with a standardized bacterial culture and incubated at 37°C for 24 hours. The wells are then inspected visually for turbidity or analyzed spectrophotometrically at 600 nm. A lower MIC value indicates higher antimicrobial potency, allowing the formulation to remain effective even when diluted by wound exudates.

7.5 In Vitro Antimicrobial Activity via Direct Inoculation

This test simulates real-world use by evaluating antimicrobial performance directly within the cream matrix. The formulation itself is inoculated with a known concentration of test organisms The inoculated product is stored at 22°C. Samples are taken at designated intervals (such as Day 1, 7, 14, and 28), neutralized, and plated for viable counts. This protocol helps verify that the active antiseptic remains available and functional within the complex lipid matrix over time, rather than becoming trapped or inactivated by the emulsifying agents.

8. Stability Studies and Stress Testing

Topical creams must maintain their chemical composition and physical structure throughout their designated shelf life. Stability studies are conducted in compliance with International Council for Harmonisation (ICH) Q1A(R2) guidelines [14].

8.1 Environmental Testing Conditions

Formulated creams are stored in final commercial packaging inside environmental stability chambers under two primary stress conditions:

• Long-Term Real-Time Conditions: Stored up to 12 months.
• Accelerated Stress Conditions: Stored for 6 months.

8.2 Evaluated Parameters

Samples are withdrawn at specific intervals (0, 1, 2, 3, and 6 months) and evaluated across several parameters to detect early signs of degradation:

• Appearance: Monitored for yellowing, color fading, or changes in gloss.
• pH: Tracked to ensure the product remains safe for the skin. Drastic changes in pH can indicate chemical breakdown of the active ingredients or excipients.
• Viscosity: Evaluated to ensure the product maintains its rheological properties. A severe drop in viscosity often precedes phase separation.
• Drug Content: Quantified using validated High-Performance Liquid Chromatography (HPLC) or UV-Visible Spectroscopy assays. The active antiseptic content must remain within 90 % to  110%of the initial value.
• Antimicrobial Activity: Re-evaluated using agar well diffusion assays to confirm that storage under thermal stress has not reduced the product's therapeutic efficacy.
• Phase Separation: Checked via visual inspection and centrifugation tests (4000 rpm for 30 minutes). The cream must show no signs of cracking, creaming, or phase separation.

9. Future Trends in Antiseptic Cream Formulations

Recent advances in topical drug delivery focus on improving stability and control over active ingredient release.

• Nano-emulsions and Lipid Nanoparticles: Utilizing Solid Lipid Nanoparticles (SLNs) and Nanostructured Lipid Carriers (NLCs) to improve skin penetration and protect delicate natural actives from oxidation.
• Synergistic Polyherbal Blends: Combining multiple botanical extracts (such as neem, turmeric, and tea tree oil) to create a broader antimicrobial spectrum while minimizing reliance on synthetic preservatives.
• Smart, pH-Responsive Systems: Designing emulsion structures that release active antiseptic compounds more rapidly in response to the alkaline pH shift often seen in infected wound tissue.

10. CONCLUSION

The successful design of an antiseptic cream depends on carefully selecting active antimicrobial agents and balancing them within a stable, non-irritating emulsion base. Oil-in-Water (O/W) systems remain preferred for most acute applications due to their high patient acceptability, cooling properties, and ease of washing. This review highlights that incorporating rigorous physicochemical, thermal, and microbiological evaluations into early-stage development is essential for producing topical formulations that meet modern clinical standards.

REFERENCES

1. Hoang TPN, Ghori MU, Conway BR. Topical antiseptic formulations for skin and soft tissue infections. Pharmaceutics. 2021;13(4):558.
2. Chen MX, Alexander KS, Baki G. Formulation and evaluation of antibacterial creams and gels containing metal ions for topical application. J Pharm. 2016;2016:5754349.
3. Lobo R, Prabhu K, Shirwaikar A, Ballal M. Formulation and evaluation of the antiseptic activity of herbal cream containing Curcuma longa and tea tree oil. J Biologically Active Products from Nature. 2011;1(1):27–32.
4. Aulton ME, Taylor KMG. Aulton's Pharmaceutics: The Design and Manufacture of Medicines. 6th ed. London: Elsevier; 2022.
5. Allen LV. Remington: The Science and Practice of Pharmacy. 23rd ed. London: Pharmaceutical Press; 2020.
6. Lachman L, Lieberman HA, Kanig JL. The Theory and Practice of Industrial Pharmacy. 4th ed. New Delhi: CBS Publishers; 2019.
7. Chauhan L, Gupta S. Creams: A review on classification, preparation methods, evaluation and its applications. J Drug Deliv Ther. 2020;10(5-S):281–289.
8. Ansel HC. Pharmaceutical Dosage Forms and Drug Delivery Systems. 11th ed. Philadelphia: Wolters Kluwer; 2021.
9. Williamson DA, Carter GP, Howden BP. Current and emerging topical antibacterials and antiseptics: agents, action and resistance patterns. Clin Microbiol Rev. 2017;30(3):827–860.
10. Sinko PJ. Martin's Physical Pharmacy and Pharmaceutical Sciences. 7th ed. Philadelphia: Lippincott Williams & Wilkins; 2017.
11. Swarbrick J. Encyclopedia of Pharmaceutical Technology. 4th ed. New York: Informa Healthcare; 2019.
12. Banker GS, Rhodes CT. Modern Pharmaceutics. 5th ed. New York: CRC Press; 2020.
13. Biswas K, Chattopadhyay I, Banerjee RK, Bandyopadhyay U. Biological activities and medicinal properties of neem (Azadirachta indica). Curr Sci. 2002;82(11):1336–1345.
14. International Council for Harmonisation (ICH). ICH Harmonised Guideline Q1A(R2): Stability Testing of New Drug Substances and Products. Geneva: ICH; 2003.
15. Indian Pharmacopoeia Commission. Indian Pharmacopoeia 2022. Ghaziabad: IPC; 2022.
16. United States Pharmacopeial Convention. USP 47–NF 42. Rockville, MD: USP Convention; 2024.
17. Love D, Kubey W, Holmes CJ. A laboratory method to evaluate formulation effects on the in vitro antimicrobial activity of topical creams and ointments. Burns. 1987;13(3):204–207.
18. Gupta P, Garg S. Semisolid dosage forms for topical drug delivery. Pharm Technol. 2018;42(7):34–42.
19. Jain NK. Controlled and Novel Drug Delivery. 1st ed. New Delhi: CBS Publishers; 2019.
20. Naik R, Bolmal U, Gupta KK, Attar MS, Desai K. Development and characterization of anti-septic cream containing turmeric, aloe vera gel and Jatyadi oil. Int J Ayurveda Pharma Res. 2025;13(2):45–53.